Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000061844

Apexbio Technology LLC Meloxicam (Mobic) 71125-38-7 10mM (in 1mL DMSO)
SDP

Catalog No. 5000061844
Encompass_Preferred

Meloxicam (CAS 71125-38-7) commercially known as Mobic is a nonsteroidal anti-inflammatory drug (NSAID) that selectively inhibits cyclooxygenase-2 (COX-2) thereby interfering with prostaglandin synthesis and mitigating inflammation and pain Its pharmacological activity against COX-2 reduces symptoms associated with rheumatoid arthritis juvenile rheumatoid arthritis and osteoarthritis such as joint pain stiffness and swelling As a COX-2 preferential inhibitor meloxicam is widely utilized as a reference compound in biomedical research examining inflammatory signaling pathways and arthritis-related disease models

Catalog No. 50-000-61844 Supplier Apexbio Technology LLC Supplier No. A84665.1
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Meloxicam (CAS 71125-38-7) commercially known as Mobic is a nonsteroidal anti-inflammatory drug (NSAID) that selectively inhibits cyclooxygenase-2 (COX-2) thereby interfering with prostaglandin synthesis and mitigating inflammation and pain Its pharmacological activity against COX-2 reduces symptoms associated with rheumatoid arthritis juvenile rheumatoid arthritis and osteoarthritis such as joint pain stiffness and swelling As a COX-2 preferential inhibitor meloxicam is widely utilized as a reference compound in biomedical research examining inflammatory signaling pathways and arthritis-related disease models

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.